Accession Number : AD1047205


Title :   Roswell Park Cancer Institute/ Howard University Prostate Cancer Scholars Program


Descriptive Note : Technical Report,30 Sep 2015,29 Sep 2016


Corporate Author : Health Research Inc. Buffalo United States


Personal Author(s) : Huss,Wendy ; Kisailus,Adam ; Hershberger,Richard ; Allen,Anna


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/1047205.pdf


Report Date : 01 Oct 2016


Pagination or Media Count : 28


Abstract : The Roswell Park/Howard University Prostate Cancer Scholars Program is designed to encourage students from under-represented minority groups to enter graduate training and ultimately careers in prostate cancer research. The three-phased program combines elements of pre-internship tele-mentoring, mentored summer research experience and post-internship mentoring activities in order to: (1) inform a student's decisions regarding graduate training, (2) motivate the pursuit of prostate cancer research with an emphasis in cancer health disparities and (3) support successful entry, transition and retention into graduate training. Two Howard University Honors Sophomore students were accepted and enrolled in the program in PGY2. Both students are currently progressing through the preparatory tele-mentoring phase of the program prior to their summer internship at the end of their junior year in 2016. One of these students conducted an additional summer experience following her Sophomore year in 2016 due to availability of funding and to provide increased research experience which will benefit her productivity. Four students accepted in 2015 completed their three semester tele-mentorship and conducted the 10 week summer experience in 2016 at Roswell Park Cancer Institute. These four students will be attending and presenting their summers research at the Society for Basic Urologic Research (SBUR) scientific conference in November.


Descriptors :   UNIVERSITIES , prostate cancer , COLLEGE STUDENTS , minorities , biomedical research


Subject Categories : Medicine and Medical Research


Distribution Statement : APPROVED FOR PUBLIC RELEASE